Works matching IS 25233548 AND DT 2024 AND VI 44 AND IP 6

Results: 9

Protein tyrosine phosphatases: emerging role in cancer therapy resistance.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 637, doi. 10.1002/cac2.12548

By:

Zhao, Min;
Shuai, Wen;
Su, Zehao;
Xu, Ping;
Wang, Aoxue;
Sun, Qiu;
Wang, Guan

Publication type:

Article

Cover Image, Volume 44, Issue 6.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 1, doi. 10.1002/cac2.12580

By:

Zhang, Xin‐Yu;
Shi, Jian‐Bo;
Jin, Shu‐Fang;
Wang, Rui‐Jie;
Li, Ming‐Yu;
Zhang, Zhi‐Yuan;
Yang, Xi;
Ma, Hai‐Long

Publication type:

Article

Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 654, doi. 10.1002/cac2.12547

By:

Lan, Chunyan;
Lu, Huaiwu;
Zhou, Lin;
Liao, Kunlun;
Liu, Junxiu;
Xie, Zhiwen;
Liang, Haixi;
Zou, Guorong;
Yang, Ting;
Xu, Qin;
Huang, Xin

Publication type:

Article

Converting "cold" to "hot": epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 601, doi. 10.1002/cac2.12546

By:

Tang, Yijia;
Cui, Guangzu;
Liu, Haicong;
Han, Ying;
Cai, Changjing;
Feng, Ziyang;
Shen, Hong;
Zeng, Shan

Publication type:

Article

Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 670, doi. 10.1002/cac2.12545

By:

Zhang, Xin‐Yu;
Shi, Jian‐Bo;
Jin, Shu‐Fang;
Wang, Rui‐Jie;
Li, Ming‐Yu;
Zhang, Zhi‐Yuan;
Yang, Xi;
Ma, Hai‐Long

Publication type:

Article

Proteomics of cell‐free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer‐progressing properties.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 695, doi. 10.1002/cac2.12542

By:

Gustafsson, Anna;
Jonasson, Emma;
Ståhlberg, Anders;
Landberg, Göran

Publication type:

Article

Positive regulation of cell proliferation by the miR‐1290‐EHHADH axis in hepatocellular carcinoma.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 705, doi. 10.1002/cac2.12536

By:

Lee, Jinkwon;
Kim, Gyeonghwa;
Han, Tae‐Su;
Jung, Eunsun;
Son, Taesang;
Kim, Kwangho;
Kwon, Kiyoon;
Roh, Yuna;
Ryu, Tae Young;
Tae, In Hwan;
Kang, Yunsang;
Lee, Byungheon;
Lee, Yu Rim;
Park, Soo Young;
Tak, Won Young;
Kim, Dae‐Soo;
Son, Mi‐Young;
Hur, Keun;
Cho, Hyun‐Soo

Publication type:

Article

The mechanism of resistance to CDK4/6 inhibition and novel combination therapy with RNR inhibition for chemo‐resistant bladder cancer.

Published in:

Cancer Communications, 2024, v. 44, n. 6, p. 700, doi. 10.1002/cac2.12532

By:

Tong, Zhichao;
Zhao, Yubo;
Bai, Shiyu;
Ebner, Benedikt;
Lienhard, Lou;
Zhao, Yuling;
Wang, Ziqi;
Pan, Qi;
Guo, Pengyu;
Bracht, Thilo;
Sitek, Barbara;
Gschwend, Jürgen E.;
Xu, Wanhai;
Nawroth, Roman

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2024, v. 44, n. 6, p. 599, doi. 10.1002/cac2.12435
Publication type:: Article